Home Other Building Blocks 156177-65-0
156177-65-0,MFCD00952084
Catalog No.:AA00AS1N

156177-65-0 | 3,9-bis((ethylthio)methyl)-K-252a

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥97%(HPLC)
in stock  
$2,090.00   $1,463.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00AS1N
Chemical Name:
3,9-bis((ethylthio)methyl)-K-252a
CAS Number:
156177-65-0
Molecular Formula:
C33H33N3O5S2
Molecular Weight:
615.7622
MDL Number:
MFCD00952084
SMILES:
CCSCc1ccc2c(c1)c1c3C(=O)NCc3c3c4c1n2[C@H]1C[C@]([C@](O1)(n4c1c3cc(cc1)CSCC)C)(O)C(=O)OC
Properties
Computed Properties
 
Complexity:
1150  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Heavy Atom Count:
43  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
8  
XLogP3:
4.4  

Literature

Title: Dual Leucine Zipper Kinase Inhibitors for the Treatment of Neurodegeneration.

Journal: Journal of medicinal chemistry 20180927

Title: Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.

Journal: Journal of medicinal chemistry 20131024

Title: Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20110601

Title: Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells.

Journal: Toxicology and applied pharmacology 20091115

Title: Targets for neuroprotection in Parkinson's disease.

Journal: Biochimica et biophysica acta 20090701

Title: [Therapy of Parkinson's disease--up to date].

Journal: Rinsho shinkeigaku = Clinical neurology 20081101

Title: Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine models.

Journal: Journal of medicinal chemistry 20080925

Title: Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.

Journal: Molecular and cellular neurosciences 20080901

Title: CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.

Journal: Molecular and cellular neurosciences 20080901

Title: Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20080116

Title: Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease.

Journal: Neurology 20071009

Title: Identification of a lectin causing the degeneration of neuronal processes using engineered embryonic stem cells.

Journal: Nature neuroscience 20070601

Title: A role for mixed lineage kinases in granule cell apoptosis induced by cytoskeletal disruption.

Journal: Journal of neurochemistry 20060301

Title: Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants.

Journal: Expert opinion on investigational drugs 20051101

Title: Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20050706

Title: Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society 20050601

Title: Brain chemotherapy from the bench to the clinic: targeting neuronal survival with small molecule inhibitors of apoptosis.

Journal: Frontiers in bioscience : a journal and virtual library 20050101

Title: Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20040815

Title: Activation of c-Jun N-terminal kinase mediates gp120IIIB- and nucleoside analogue-induced sensory neuron toxicity.

Journal: Experimental neurology 20040801

Title: American Chemical Society--227th annual meeting. Neuroprotection. 28 March - 1 April 2004, Anaheim, CA, USA.

Journal: IDrugs : the investigational drugs journal 20040501

Title: Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells.

Journal: Brain research 20040402

Title: Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.

Journal: Biochimica et biophysica acta 20040311

Title: Improvement of embryonic dopaminergic neurone survival in culture and after grafting into the striatum of hemiparkinsonian rats by CEP-1347.

Journal: Journal of neurochemistry 20040201

Title: Mixed-lineage kinases: a target for the prevention of neurodegeneration.

Journal: Annual review of pharmacology and toxicology 20040101

Title: JNK-independent activation of c-Jun during neuronal apoptosis induced by multiple DNA-damaging agents.

Journal: The Journal of biological chemistry 20030620

Title: K252a and CEP1347 are neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK.

Journal: The Journal of biological chemistry 20021220

Title: Identification of JNK-dependent and -independent components of cerebellar granule neuron apoptosis.

Journal: Journal of neurochemistry 20021101

Title: Mixed lineage kinase 3 mediates gp120IIIB-induced neurotoxicity.

Journal: Journal of neurochemistry 20020901

Title: Mixed lineage kinase activity of indolocarbazole analogues.

Journal: Bioorganic & medicinal chemistry letters 20020121

Title: Inhibition of the c-Jun N-terminal kinase signaling pathway by the mixed lineage kinase inhibitor CEP-1347 (KT7515) preserves metabolism and growth of trophic factor-deprived neurons.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20020101

Title: The K252a derivatives, inhibitors for the PAK/MLK kinase family selectively block the growth of RAS transformants.

Journal: Cancer journal (Sudbury, Mass.) 20020101

Title: Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases.

Journal: Progress in medicinal chemistry 20020101

Title: Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family.

Journal: The Journal of biological chemistry 20010706

Title: CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis.

Journal: Journal of neurochemistry 20010501

Title: Stress kinase inhibition modulates acute experimental pancreatitis.

Journal: World journal of gastroenterology 20010415

Title: Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20000101

Title: CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.

Journal: The Journal of pharmacology and experimental therapeutics 19990201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:156177-65-0 Molecular Formula|156177-65-0 MDL|156177-65-0 SMILES|156177-65-0 3,9-bis((ethylthio)methyl)-K-252a